Many patients who struggle with obesity also suffer from high blood pressure, high cholesterol, sleep apnea, fatty liver, joint pain, back pain, pre-diabetes
A separate prespecified SELECT analysis confirmed that semaglutide reduced cardiovascular events irrespective of baseline HbA1c or change in HbA1c, including in normoglycemic patients and in patients who showed no glycemic improvement whatsoever
Weight-management formulations carry warnings about suicidal ideation and behavior, though the FDA has stated that current evidence is insufficient to establish a causal relationship
In clinical trials, people with type 2 diabetes who took Rybelsus showed significantly lower blood sugar levels on standard hemoglobin A1C tests than those who took a placebo (Anderson, 2020
In the brain, semaglutide activates GLP-1 receptors in the hypothalamus and brainstem